SCHEMBL21091003

SCHEMBL21091003

Cc1cccc(/C(N)=C/N(C)N)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ TRPA1 O75762 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ LMNA P02545 2/20 0.33
▸ AKR1B10 O60218 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ DHFR P00374 1/20 0.33
▸ MPO P05164 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ AKR1B1 P15121 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24359840 0.83 MAPT (0.36) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL27299447 0.75 ESR1 (0.38) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL22702887 0.73 ALDH1A1 (0.39) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL21091028 0.71 ESR1 (0.38) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL6830746 0.69 TRPA1 (0.44) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL8445208 0.69 TRPA1 (0.44) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL6761818 0.69 MAPT (0.53) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL4046937 0.69 TRPA1 (0.44) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL160022 0.69 ESR1 (0.49) ESR1ESR2ALDH1A1MAPTTRPA1
SCHEMBL30933674 0.69 ESR1 (0.49) ESR1ESR2ALDH1A1MAPTTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495358-A1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Bristol-Myers Squibb Company (US) 2019-06-12 — — EP disclosed
Send feedback